Quick Answer
Accustem Sciences Inc. reported R&D Expense of $138.3 thousand for fiscal year 2024.
Accustem Sciences Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $138.3K | -1.0% |
| 2023 | $139.7K | -47.7% |
| 2022 | $266.9K | +264.0% |
| 2021 | $73.3K | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $72.7K | +131.5% | +20.8% |
| June 30, 2025 | $60.2K | +44.2% | +112.4% |
| March 31, 2025 | $28.3K | +22.2% | -9.8% |
| September 30, 2024 | $31.4K | +57.4% | -24.8% |
| June 30, 2024 | $41.7K | +186.4% | +80.0% |
| March 31, 2024 | $23.2K | +48.7% | +16.3% |
| September 30, 2023 | $20.0K | -65.8% | +36.9% |
| June 30, 2023 | $14.6K | -73.2% | -6.6% |
- Accustem Sciences Inc. showed a decrease of -1.0% in R&D Expense compared to the prior fiscal year.
- Over the 2021–2024 period, Accustem Sciences Inc.’s r&d expense has grown by 88.6% (from $73.3 thousand to $138.3 thousand).
- The most recent figure is from Accustem Sciences Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 3, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: